-
1
-
-
0036233749
-
Update on Kaposi's sarcoma and other HHV8 diseases. Part 1. Epidemiology, environmental predispositions, clinical manifestations, and therapy
-
Hengge UR, Ruzicka T, Tyring SK et al. Update on Kaposi's sarcoma and other HHV8 diseases. Part 1. Epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet Infect Dis 2002; 2:281-92.
-
(2002)
Lancet Infect Dis
, vol.2
, pp. 281-292
-
-
Hengge, U.R.1
Ruzicka, T.2
Tyring, S.K.3
-
2
-
-
0034035012
-
Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients
-
Dupont C, Vasseur E, Beauchet A et al. Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients. AIDS 2000; 14:987-93.
-
(2000)
AIDS
, vol.14
, pp. 987-993
-
-
Dupont, C.1
Vasseur, E.2
Beauchet, A.3
-
3
-
-
0026428123
-
Studies with RP 56976 (taxotere): A semisynthetic analogue of taxol
-
Ringel I, Horwitz SB. Studies with RP 56976 (taxotere): a semisynthetic analogue of taxol. J Natl Cancer Inst 1991; 83:288-91.
-
(1991)
J Natl Cancer Inst
, vol.83
, pp. 288-291
-
-
Ringel, I.1
Horwitz, S.B.2
-
4
-
-
0037430246
-
Comparison of antiangiogenic activities using paclitaxel (taxol) and docetaxel (taxotere)
-
Grant DS, Williams TL, Zahaczewsky M, Dicker AP. Comparison of antiangiogenic activities using paclitaxel (taxol) and docetaxel (taxotere). Int J Cancer 2003; 104:121-9.
-
(2003)
Int J Cancer
, vol.104
, pp. 121-129
-
-
Grant, D.S.1
Williams, T.L.2
Zahaczewsky, M.3
Dicker, A.P.4
-
5
-
-
0029061777
-
Treatment of HIV-associated Kaposi's sarcoma with paclitaxel
-
Saville MW, Lietzau J, Pluda JM et al. Treatment of HIV-associated Kaposi's sarcoma with paclitaxel. Lancet 1995; 346:26-8.
-
(1995)
Lancet
, vol.346
, pp. 26-28
-
-
Saville, M.W.1
Lietzau, J.2
Pluda, J.M.3
-
6
-
-
0031911323
-
Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma
-
Welles L, Saville MW, Lietzau J et al. Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma. J Clin Oncol 1998; 16:1112-21.
-
(1998)
J Clin Oncol
, vol.16
, pp. 1112-1121
-
-
Welles, L.1
Saville, M.W.2
Lietzau, J.3
-
7
-
-
0033064114
-
Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma
-
Gill PS, Tulpule A, Espina BM et al. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma. J Clin Oncol 1999; 17:1876-83.
-
(1999)
J Clin Oncol
, vol.17
, pp. 1876-1883
-
-
Gill, P.S.1
Tulpule, A.2
Espina, B.M.3
-
8
-
-
0036644981
-
Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi's sarcoma
-
Tulpule A, Groopman J, Saville MW et al. Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi's sarcoma. Cancer 2002; 95:147-54.
-
(2002)
Cancer
, vol.95
, pp. 147-154
-
-
Tulpule, A.1
Groopman, J.2
Saville, M.W.3
-
9
-
-
10744225451
-
Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: Clinical and angiogenic correlations
-
Stebbing J, Wildfire A, Portsmouth S et al. Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: clinical and angiogenic correlations. Ann Oncol 2003; 14:1660-6.
-
(2003)
Ann Oncol
, vol.14
, pp. 1660-1666
-
-
Stebbing, J.1
Wildfire, A.2
Portsmouth, S.3
-
10
-
-
0024432019
-
Kaposi's sarcoma in the acquired immune deficiency syndrome: A proposal for uniform evaluation, response, and staging criteria
-
Krown SE, Metroka C, Wernz JC for the AIDS Clinical Trials Group Oncology Committee. Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. J Clin Oncol 1989; 7:1201-7.
-
(1989)
J Clin Oncol
, vol.7
, pp. 1201-1207
-
-
Krown, S.E.1
Metroka, C.2
Wernz, J.C.3
-
11
-
-
0344412949
-
Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma
-
Nasti G, Martellotta F, Berretta M et al. Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma. Cancer 2003; 98:2440-6.
-
(2003)
Cancer
, vol.98
, pp. 2440-2446
-
-
Nasti, G.1
Martellotta, F.2
Berretta, M.3
-
12
-
-
0031861021
-
Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma: Results of a randomized phase III clinical trial
-
Northfelt DW, Dezube BJ, Thommes JA et al. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial. J Clin Oncol 1998; 16:2445-51.
-
(1998)
J Clin Oncol
, vol.16
, pp. 2445-2451
-
-
Northfelt, D.W.1
Dezube, B.J.2
Thommes, J.A.3
-
14
-
-
4243400347
-
Activity of Taxotere (docetaxel) as therapy for pretreated HIV-associated Kaposi sarcoma: An ANRS trial
-
ASCO proceedings 47a
-
Boue F, Zaikas G, Lancar R et al. Activity of Taxotere (docetaxel) as therapy for pretreated HIV-associated Kaposi sarcoma: an ANRS trial. J Clin Oncol 1998; 17 [ASCO proceedings 47a].
-
(1998)
J Clin Oncol
, vol.17
-
-
Boue, F.1
Zaikas, G.2
Lancar, R.3
-
15
-
-
0042386692
-
AIDS-related Kaposi's sarcoma: Evaluation of potential new prognostic factors and assessment of the ALOS clinical trial group staging system in the HAART era-the Italian Cooperative Group on AIDS and Tumors and the Italian cohort of patients naive from antiretrovirals
-
Nasti G, Talamini R, Antinori A et al. AIDS-related Kaposi's sarcoma: evaluation of potential new prognostic factors and assessment of the ALOS clinical trial group staging system in the HAART era-the Italian Cooperative Group on AIDS and Tumors and the Italian cohort of patients naive from antiretrovirals. J Clin Oncol 2003; 21:2876-82.
-
(2003)
J Clin Oncol
, vol.21
, pp. 2876-2882
-
-
Nasti, G.1
Talamini, R.2
Antinori, A.3
|